Investing.com - Financial Markets Worldwide

Irhythm Technologies stock hits 52-week high at 172.74 USD

Published 03/09/2025, 15:18
Irhythm Technologies stock hits 52-week high at 172.74 USD
IRTC
1.04%

Shares of iRhythm Technologies Inc (IRTC), a $5.5 billion market cap company, have reached a new 52-week high, closing at 172.74 USD. According to InvestingPro analysis, the stock appears overvalued at current levels. This milestone reflects a significant upward trajectory, with the stock experiencing a remarkable 1-year change of 149.35%. The company, which specializes in innovative cardiac monitoring solutions, has seen its stock price surge over the past year, driven by strong market demand and positive investor sentiment. With revenue growth of 22.4% and a robust financial health score rated as "GOOD" by InvestingPro, the company shows strong operational momentum. This latest high underscores the company’s growing market presence, positioning iRhythm Technologies as a notable player in the medical technology sector. Analysts maintain a strong buy consensus with a high price target of $200. Discover more insights and 8 additional ProTips with InvestingPro’s comprehensive research report.

In other recent news, iRhythm Technologies reported better-than-expected earnings for the second quarter of 2025. The company posted an adjusted net loss of $0.32 per share, surpassing analysts’ forecast of a $0.51 loss per share. Revenue reached $186.7 million, exceeding expectations and representing a 26.1% increase compared to the previous year. BofA Securities initiated coverage on iRhythm Technologies with a Buy rating and set a price target of $200.00, highlighting the company’s innovative approach to cardiac monitoring. In contrast, Spruce Point Capital Management released a short report on iRhythm, suggesting a potential long-term downside of 40%-70% for the stock. The investment firm expressed concerns regarding the company’s cardiac monitoring products and management credibility. These developments present a complex picture for investors to consider.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.